Table 4.

Cause of mortality by DLCOcSB > 60% or ≤60% of predicted in patients undergoing auto-HSCT conditioned with BEAM

DLCOcSB > 60% of predictedDLCOcSB ≤ 60% of predicted
Patients, n 278 37 
Alive 211 (76) 18 (49) 
Relapse 57 (20) 10 (27) 
NRM 8 (3) 7 (19) 
 Cause of death (months after auto-HSCT) Pneumocystis jiroveci pneumonia (5.6) Aspergillosis (0.6) 
 Pneumonia, hypoxia by aspiration (0.7) Sepsis by Pseudomonas aeruginosa (10.2) 
 Pneumonic sepsis (4.0) ST-elevated myocardial infarction (17.8) 
 ARDS (0.5) CNS-organic psycho-syndrome (2.1) 
 Guillain-Barré syndrome (32) Multiorgan dysfunction (1.3) 
 Acute abdomen (3.7) CNS hemorrhage (0.4) 
 Hemophagocytic syndrome (43.8) Second neoplasia (AML) (41.7) 
 Second neoplasia (tongue carcinoma) (55)  
 Unknown cause of death, n (%) 2 (1) 2 (5) 
DLCOcSB > 60% of predictedDLCOcSB ≤ 60% of predicted
Patients, n 278 37 
Alive 211 (76) 18 (49) 
Relapse 57 (20) 10 (27) 
NRM 8 (3) 7 (19) 
 Cause of death (months after auto-HSCT) Pneumocystis jiroveci pneumonia (5.6) Aspergillosis (0.6) 
 Pneumonia, hypoxia by aspiration (0.7) Sepsis by Pseudomonas aeruginosa (10.2) 
 Pneumonic sepsis (4.0) ST-elevated myocardial infarction (17.8) 
 ARDS (0.5) CNS-organic psycho-syndrome (2.1) 
 Guillain-Barré syndrome (32) Multiorgan dysfunction (1.3) 
 Acute abdomen (3.7) CNS hemorrhage (0.4) 
 Hemophagocytic syndrome (43.8) Second neoplasia (AML) (41.7) 
 Second neoplasia (tongue carcinoma) (55)  
 Unknown cause of death, n (%) 2 (1) 2 (5) 

Unless otherwise noted, data are n (%). DLCOcSB values were not available for 19 patients (5.4%) before auto-HSCT and prior to conditioning with BEAM.

AML, acute myeloid leukemia; ARDS, acute respiratory distress syndrome.

or Create an Account

Close Modal
Close Modal